Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Nature Communications|December 10, 2015
Signal transduction in light-oxygen-voltage receptors lacking the adduct-forming cysteine residueEstella F Yee, Ralph P Diensthuber, Anand T Vaidya, et al.
The Journal of Biological Chemistry|August 30, 2002
The CY domain of the Fcgamma RIa alpha-chain (CD64) alters gamma-chain tyrosine-based signaling and phagocytosisJeffrey C Edberg, Hongwei Qin, Andrew W Gibson, et al.
Biosensors|March 24, 2022
Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and SeroprevalenceElda A Flores-Contreras, Reyna Berenice González-González, Iram P Rodríguez-Sánchez, et al.
Seminars in Arthritis and Rheumatism|December 10, 2016
Pilot study of a multidisciplinary gout patient education and monitoring programTheodore R Fields, Adam Rifaat, Arthur M F Yee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 3, 2025
KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor RegressionYouwei Qiao, Matthew F Yee, Chaitanya N Parikh, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 14, 2022
A Proactive Outreach Strategy Using a Local Area Code to Refer Unassisted Smokers in a Safety Net Health System to a Quitline: A Pragmatic Randomized TrialCindy V Valencia, Melanie S Dove, Sharon E Cummins, et al.
Hepatology (Baltimore, Md.)|September 11, 2012
A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in miceJuan E Puche, Youngmin A Lee, Jingjing Jiao, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
KRAS withdrawal in Cholangiocarcinoma leads to immune infiltration and tumor regressionYouwei Qiao, Matthew F Yee, Chaitanya N Parikh, et al.
Pageof 19